79654-39-0 Usage
Uses
Used in Organic Synthesis:
(5-methyl-isoxazol-3-yl)-diphenyl-methanol is used as a reagent in organic synthesis for its ability to facilitate various chemical reactions and form a wide range of products.
Used in Pharmaceutical Production:
(5-methyl-isoxazol-3-yl)-diphenyl-methanol serves as a building block in the production of pharmaceuticals, contributing to the development of new drugs and therapies.
Used in Agrochemicals:
(5-methyl-isoxazol-3-yl)-diphenyl-methanol is also utilized in the creation of agrochemicals, which are chemicals used in agriculture for various purposes, such as pest control and crop protection.
Used in Material Development:
(5-methyl-isoxazol-3-yl)-diphenyl-methanol has potential applications in the development of new materials, thanks to its unique chemical properties and solubility characteristics.
Used in Medicinal Chemistry Research:
(5-methyl-isoxazol-3-yl)-diphenyl-methanol is a subject of ongoing scientific investigation in medicinal chemistry, where it may contribute to the discovery of novel therapeutic agents and treatment strategies.
Used in Antifungal and Antibacterial Applications:
Due to its biological activities, (5-methyl-isoxazol-3-yl)-diphenyl-methanol is used as an antifungal and antibacterial agent, potentially offering new solutions for controlling infections and promoting public health.
Check Digit Verification of cas no
The CAS Registry Mumber 79654-39-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,9,6,5 and 4 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 79654-39:
(7*7)+(6*9)+(5*6)+(4*5)+(3*4)+(2*3)+(1*9)=180
180 % 10 = 0
So 79654-39-0 is a valid CAS Registry Number.
79654-39-0Relevant academic research and scientific papers
PHARMACEUTICAL PRODUCT COMPRISING A MUSCARINIC RECEPTOR ANTAGONIST AND A SECOND ACTIVE INGREDIENT
-
Page/Page column 32, (2010/04/03)
The invention provides a pharmaceutical product, kit or composition comprising a first active ingredient which is a selected muscarinic receptor antagonist, and a second active ingredient which is selected from a phosphodiesterase inhibitor, a modulator of chemokine receptor function, an inhibitor of kinase function, a protease inhibitor, a steroidal glucocorticoid receptor agonist, a non-steroidal glucocorticoid receptor agonist and a purinoceptor antagonist, of use in the treatment of respiratory diseases such as chronic obstructive pulmonary disease and asthma.
HETEROCYCLIC COMPOUNDS USED IN THE TREATMENT OF DISEASES WHERE ENHANCED M3 RECEPTOR ACTIVATION IS IMPLICATED
-
Page/Page column 39, (2010/04/03)
The invention provides named compounds of formula (I), pharmaceutical compositions containing them, a process for preparing the pharmaceutical compositions and their use in in the treatment of diseases where enhanced M3 receptor activation is implicated.
NITROGEN CONTAINING HETEROCYCLIC COMPOUNDS USEFUL AS BIFUNCTIONAL MODULATORS OF M3 RECEPTORS AND BETA-2 RECEPTORS
-
Page/Page column 45-46, (2010/04/03)
The present invention relates to named compounds of the formula (I) having both M3 receptor antagonist and β2 agonist activity; compositions comprising such compounds; the use of such compounds in therapy (such as respiratory tract disorders); and a metho
